Integrative Therapeutics

Garlitrin 4000

Serving
1 Tablet(s)
Form
tablet
UPC
871791000452
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
3
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

1 active ingredients
IngredientAmount% DV
Garlic (Allium sativum) bulb extract
GarlicUNII · V1V998DC17
320 mg
Flagged excipients

1 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

FDA CAERS · adverse event context
3
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Cellulose · Silicon Dioxide · Sodium Carboxymethyl Cellulose · Hydroxypropyl Methylcellulose · Ethylcellulose · Calcium Stearate · Hydroxypropylcellulose · Sodium Alginate · Medium Chain Triglycerides · Glycerin · Oleic Acid · Stearic Acid

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.